학술논문

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection
Document Type
article
Source
The Journal of Infectious Diseases. 213(9)
Subject
Vaccine Related
Rare Diseases
Vector-Borne Diseases
Prevention
Immunization
Infectious Diseases
Emerging Infectious Diseases
Biodefense
Infection
Good Health and Well Being
Antibodies
Neutralizing
Antibodies
Viral
Child
Child
Preschool
Dengue
Dengue Virus
Humans
Kinetics
Longitudinal Studies
Thailand
dengue
neutralizing antibody
longitudinal antibody kinetics
vaccine
Biological Sciences
Medical and Health Sciences
Microbiology
Language
Abstract
The immune response to dengue virus (DENV) infection is complex and not fully understood. Using longitudinal data from 181 children with dengue in Thailand who were followed for up to 3 years, we describe neutralizing antibody kinetics following symptomatic DENV infection. We observed that antibody titers varied by serotype, homotypic vs heterotypic responses, and primary versus postprimary infections. The rates of change in antibody titers over time varied between primary and postprimary responses. For primary infections, titers increased from convalescence to 6 months. By comparing homotypic and heterotypic antibody titers, we saw an increase in type specificity from convalescence to 6 months for primary DENV3 infections but not primary DENV1 infections. In postprimary cases, there was a decrease in titers from convalescence up until 6 months after infection. Beginning 1 year after both primary and postprimary infections, there was evidence of increasing antibody titers, with greater increases in children with lower titers, suggesting that antibody titers were boosted due to infection and that higher levels of neutralizing antibody may be more likely to confer a sterilizing immune response. These findings may help to model virus transmission dynamics and provide baseline data to support the development of vaccines and therapeutics.